CommercialCoverageMedium impact
08.01.15g, Golimumab (Simponi Aria®) Intravenous (IV) Injection
Independence Blue Cross·Rheumatology, Gastroenterology, Internal Medicine·Pharmacy
Effective date
Aug 6, 2025
We identified it
Jun 19, 2026
Summary
This is a reissued policy for Golimumab (Simponi Aria®) IV injection effective August 6, 2025. The policy document itself was not provided with specific coverage changes, requirements, or billing guidance. The billing team must obtain the full policy text from the URL provided to identify any coverage criteria, prior authorization requirements, dosing limits, or billing code updates that may affect claim submission.
Action Required
By August 6, 2025: Billing team must retrieve and review the complete policy text from https://medpolicy.ibx.com/ibc/Commercial/Pages/Site-Activity-View.aspx?FilterField1=MPSiteActivityLogMonth&FilterValue1=08&FilterField2=MPSiteActivityLogYear&FilterValue2=2025#commercial-08-01-15g. Document any changes to prior authorization requirements, covered indications, dosing schedules, or billing codes for Golimumab IV in the billing system. Update encounter templates and provider notifications if prior auth or documentation requirements have changed. Ensure all staff processing Golimumab IV claims are trained on the reissued policy before the effective date to prevent claim denials.